Vial

DECEMBER 8, 2023

In this article by Vial CRO (Contract Research Organization), we will explore five anticipated ophthalmology therapies in 2024, offering valuable insights for biotech startups, CROs, pharma companies, clinical sites, and scientists planning to conduct clinical trials.

Therapies 52

Therapies Clinical Trials Trials Treatment 52

Drug Discovery World

OCTOBER 16, 2023

Despite the overall reduction in major pharma R&D centres in the UK, global pharma companies continue to engage with academic and biotech organisations here, particularly in hotspots such as the Golden Triangle, the Northwest, and Scotland, through the strong networks that have been developed between these organisations.

Drugs 189

Drugs Science Therapies Targeted Protein Degradation 189

The Pharma Data

SEPTEMBER 11, 2020

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. “The Saama Technologies, Inc. , Saama Technologies, Inc. ,

Clinical Trials 52

Clinical Trials Pharma Companies Hospitals Trials 52

Advarra

JUNE 14, 2022

Often, low accrual or delays in clinical trials stem from an undersized pipeline of potential participants. When site staff must manually find participants for trials, or even when automated recruitment solutions don’t deliver as promised, it puts the trial’s viability at stake, with sites and sponsors in the hot seat.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Research 52

Quanticate

OCTOBER 16, 2020

Gathering all the heterogenous data and mapping to the internal standards of the pharma companies proved to be the greatest challenge of the time. By the end of 2007, and towards the beginning of 2008, the Clinical Data Interchange Standards Consortium (CDISC) gained ground in its mission to develop a global set of standards.

Pharma Companies 52

Pharma Companies FDA International Drugs 52

Drug Discovery World

AUGUST 7, 2024

Pharma R&D has been heading in the wrong direction, becoming progressively less efficient over the last few decades. Large pharma companies now spend more than $6 billion 4 on R&D per approved drug, compared to just $40 million 5 (in today’s dollars) in the 1950s, with approximately 85% of that spending coming after discovery.

Pharma R&D 173

Pharma R&D Clinical Trials Pharma Companies Trials 173

H1 Blog

JUNE 26, 2024

In a recent interview, Daniel Perez, the Director and Global Head of Health Equity for Worldwide Clinical Trials shared insights on health equity from personal and professional experiences. Perez spoke about the opportunities and challenges in health equity and the role of pharma companies and CROs to drive more equitable research.

Clinical Trials 59

Clinical Trials Trials FDA Pharma Companies 59

Drug Discovery World

OCTOBER 7, 2022

TH : Increasingly, large pharma companies need scale, agility and access to academic partnerships to succeed. This funding is distributed between funding discovery research at our core institutes, and at universities around the UK, clinical research, cancer grand challenges, and translational research. .

Pharma Companies 130

Pharma Companies Science Research Drug Development 130

The Anticancer Fund

JUNE 7, 2022

This is another study that is strongly supportive of replication and further development, including clinical trial development. In both newly diagnosed and recurrent PDX models the drug was shown to be non-toxic and to have meaningful anti-GBM activity - including a survival benefit.

Clinical Trials 40

Clinical Trials Drugs Trials Pharmacokinetics 40

The Pharma Data

OCTOBER 14, 2020

The designation of lanifibranor as a Breakthrough Therapy for the treatment of NASH follows the publication in June 2020 of positive topline results from Inventiva’s NATIVE Phase IIb clinical trial with lanifibranor in NASH patients. The trial plans to evaluate safety, tolerability, cytokine profile and efficacy parameters.

Clinical Trials 52

Clinical Trials Trials Pharmaceuticals Pharmaceutical Companies 52